Radiation Free Chemotherapy for Early Hodgkin Lymphoma
NCT04866654
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Hodgkin Lymphoma
Interventions
DRUG:
Nivolumab 10 MG/ML
Sponsor
Medical University of Gdansk